Literature DB >> 21742811

Reticence to prescribe: utilization of expedited partner therapy among obstetrics providers in Arizona.

M M Taylor1, M G Collier, M M Winscott, T Mickey, B England.   

Abstract

Expedited partner therapy (EPT) is the practice of providing an extra dose or prescription of antibiotic to patients diagnosed with chlamydia or gonorrhoea to deliver to their sexual partner(s). Obstetrical providers who delivered more than 20 infants in Maricopa County, Arizona, USA, during the year 2008 were surveyed by telephone regarding their use of EPT. A total of 142 eligible respondents completed the survey, representing 34% (142/421) of the delivering providers, 67 (47%) of whom reported the use of EPT in their clinics. Having received information about EPT was significantly associated with its use (67% versus 41%) (P = 0.008). The most common reasons for not using EPT included the inability to obtain allergy history in partners (24%) and concern for liability (11%). Additional education regarding the use of EPT may increase the use of this personal and public health tool among some obstetrics providers in Maricopa County; however, concerns for liability may limit broad utilization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21742811      PMCID: PMC6785745          DOI: 10.1258/ijsa.2011.010492

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  11 in total

1.  The legal status of patient-delivered partner therapy for sexually transmitted infections in the United States: a national survey of state medical and pharmacy boards.

Authors:  Matthew R Golden; Uzoeshi Anukam; Donald H Williams; H Hunter Handsfield
Journal:  Sex Transm Dis       Date:  2005-02       Impact factor: 2.830

2.  Effect of expedited treatment of sex partners on recurrent or persistent gonorrhea or chlamydial infection.

Authors:  Matthew R Golden; William L H Whittington; H Hunter Handsfield; James P Hughes; Walter E Stamm; Matthew Hogben; Agnes Clark; Cheryl Malinski; Jennifer R L Helmers; Katherine K Thomas; King K Holmes
Journal:  N Engl J Med       Date:  2005-02-17       Impact factor: 91.245

3.  Patient-delivered partner treatment and other partner management strategies for sexually transmitted diseases used by New York City healthcare providers.

Authors:  Meighan E Rogers; Kelly M Opdyke; Susan Blank; Julia A Schillinger
Journal:  Sex Transm Dis       Date:  2007-02       Impact factor: 2.830

4.  Patient-delivered partner treatment for male urethritis: a randomized, controlled trial.

Authors:  Patricia Kissinger; Hamish Mohammed; Gwangi Richardson-Alston; Jami S Leichliter; Stephanie N Taylor; David H Martin; Thomas A Farley
Journal:  Clin Infect Dis       Date:  2005-07-19       Impact factor: 9.079

5.  Patient-delivered partner therapy for sexually transmitted diseases as practiced by U.S. physicians.

Authors:  Matthew Hogben; Donna H McCree; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2005-02       Impact factor: 2.830

6.  Expedited partner therapy: a robust intervention.

Authors:  Frances Shiely; Kevin Hayes; Katherine K Thomas; Roxanne P Kerani; James P Hughes; William L H Whittington; King K Holmes; H Hunter Handsfield; Matthew Hogben; Matthew R Golden
Journal:  Sex Transm Dis       Date:  2010-10       Impact factor: 2.830

Review 7.  California guidelines for expedited partner therapy for Chlamydia trachomatis and Neisseria gonorrhoeae.

Authors:  Heidi M Bauer; Dan Wohlfeiler; Jeffrey D Klausner; Sarah Guerry; Robert A Gunn; Gail Bolan
Journal:  Sex Transm Dis       Date:  2008-03       Impact factor: 2.830

8.  Clinical toleration and safety of azithromycin.

Authors:  S Hopkins
Journal:  Am J Med       Date:  1991-09-12       Impact factor: 4.965

9.  Patient-delivered partner treatment with azithromycin to prevent repeated Chlamydia trachomatis infection among women: a randomized, controlled trial.

Authors:  Julia A Schillinger; Patricia Kissinger; Helene Calvet; William L H Whittington; Ray L Ransom; Maya R Sternberg; Stuart M Berman; Charlotte K Kent; David H Martin; M Kim Oh; H Hunter Handsfield; Gail Bolan; Lauri E Markowitz; J Dennis Fortenberry
Journal:  Sex Transm Dis       Date:  2003-01       Impact factor: 2.830

10.  Azithromycin versus doxycycline for genital chlamydial infections: a meta-analysis of randomized clinical trials.

Authors:  Chuen-Yen Lau; Azhar K Qureshi
Journal:  Sex Transm Dis       Date:  2002-09       Impact factor: 2.830

View more
  6 in total

1.  Incorporation of Social Determinants of Health in the Peer-Reviewed Literature: A Systematic Review of Articles Authored by the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.

Authors:  Eleanor E Friedman; Hazel D Dean; Wayne A Duffus
Journal:  Public Health Rep       Date:  2018-06-06       Impact factor: 2.792

2.  A historical note on the association between the legal status of expedited partner therapy and physician practice.

Authors:  Ryan Cramer; Matthew Hogben; H Hunter Handsfield
Journal:  Sex Transm Dis       Date:  2013-05       Impact factor: 2.830

3.  Use of Patient-Delivered Partner Therapy in US College Settings: Associations With Legality, Perceived Legality and Other Sexual and Reproductive Health Services.

Authors:  Matthew Hogben; Alexandra Caccamo; Oscar Beltran; Ryan Cramer; Melissa A Habel
Journal:  Sex Transm Dis       Date:  2017-11       Impact factor: 2.830

4.  The legal aspects of expedited partner therapy practice: do state laws and policies really matter?

Authors:  Ryan Cramer; Jami S Leichliter; Mark R Stenger; Penny S Loosier; Lauren Slive
Journal:  Sex Transm Dis       Date:  2013-08       Impact factor: 2.830

Review 5.  Expedited partner therapy for sexually transmitted infections.

Authors:  Matthew Hogben; Sarah Kidd; Gale R Burstein
Journal:  Curr Opin Obstet Gynecol       Date:  2012-10       Impact factor: 1.927

6.  Use of Expedited Partner Therapy for Sexually Transmitted Diseases in College and University Health Centers in the United States, 2011-2012.

Authors:  Ryan Cramer; Nina Martinez; Craig Roberts; Melissa A Habel; E Victor Leino; Jami S Leichliter
Journal:  Sex Transm Dis       Date:  2015-10       Impact factor: 2.830

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.